Introduction {#s1}
============

The ventral tegmental area (VTA) is an heterogeneous brain region containing distinctive neuronal populations essential for the expression of motivated behaviors and reinforcement ([@bib5]; [@bib64]; [@bib3]; [@bib17]; [@bib6]; [@bib61]). The VTA comprises dopaminergic (\~65%), GABAergic (\~30%), and glutamatergic neurons (\~5%) ([@bib37]; [@bib68]) that receive inputs from diverse brain regions, including the laterodorsal tegmentum (LDT) ([@bib66]; [@bib16]; [@bib40]; [@bib39]).

Several studies have shown that exposure to unexpected rewards, or cues that predict rewards, can activate VTA dopaminergic neurons culminating in the release of dopamine in the nucleus accumbens (NAc) ([@bib48]; [@bib56]; [@bib55]; [@bib50]; [@bib13]). Importantly, this activity is tightly modulated by cholinergic projections ([@bib42]; [@bib43]), with an additional contribution of glutamatergic projections, arising from the LDT ([@bib16]; [@bib39]; [@bib29]). This input is vital for the activity of dopaminergic cells in the VTA, facilitating dopamine-related behaviors involved in reward signaling or encoding reward prediction signals ([@bib31]). In agreement, recent studies have shown that optogenetic stimulation of LDT neurons that project to the VTA enhances conditioned place preference ([@bib29]) and operant responses in rodents ([@bib54]).

Notably, different labs have shown that the mesolimbic system is particularly vulnerable to the effects of prenatal stress/high levels of glucocorticoids (GCs) ([@bib33]; [@bib10]; [@bib34]; [@bib30]; [@bib46]; [@bib11]; [@bib52]). These changes may increase the risk to develop different neuropsychiatric disorders in adulthood, namely depression, anxiety and addiction ([@bib51]; [@bib47]). Surprisingly, very few studies have focused on the impact of stress/GCs in the cholinergic system. This is particularly intriguing because GCs can induce acetylcholine release ([@bib18]; [@bib22]; [@bib26]) and bind to GC-responsive elements of cholinergic enzymes, namely choline acetyltransferase (ChAT) and acetylcholine esterase (AChE) to control their expression ([@bib7]). In accordance, we have previously shown that prenatal GC exposure induces a long-lasting hyperanxious state associated with an increase in the recruitment of cholinergic cells from the LDT ([@bib12]), suggesting that GCs are able to *program* the LDT, which prompted us to evaluate the impact of prenatal GC in the LDT-VTA circuitry and its impact in reward-related behaviors.

Results {#s2}
=======

Sustained cholinergic dysfunction in iuGC animals {#s2-1}
-------------------------------------------------

Previous data from our team suggested that LDT cholinergic cells were differentially recruited in response to an adverse stimulus ([@bib12]) in a model of *in utero* GC (iuGC) exposure at gestation days 18 and 19 ([@bib9]). Considering this, we first evaluated the impact of GCs on the cholinergic circuitry of iuGC animals. We quantified ChAT^+^ cells in the LDT of 3, 30 and 90 days old animals ([Figure 1a--c](#fig1){ref-type="fig"}) and observed an effect of iuGC treatment (Two-way ANOVA; F~(1,25)~ = 19.31, p=0.0002). iuGC animals had a significant increase in the density of the cholinergic population of the LDT at 30 days of age (*post-hoc* Bonferroni; CTR~(30\ days)~ vs. iuGC~(30\ days)~: t~(25)~ = 2.616, p=0.0446) that persisted until adulthood (*post-hoc* Bonferroni; CTR~(90\ days)~ vs. iuGC~(90\ days)~: t~(25)~ = 3.971, p=0.0016). Other brain regions containing cholinergic neurons such as the nucleus basalis of Meynert or the NAc remained unaltered ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

![Prenatal exposure to glucocorticoids alters LDT cholinergic system.\
(**a**) Schematic representation of the LDT. (**b**) Coronal section of the LDT showing ChAT immunohistochemistry. (**c**) iuGC animals present increased number of ChAT^+^ cells in the LDT at postnatal day 30 and 90. (**d**) Real-time PCR analysis revealed that ChAT mRNA levels are increased in the LDT of iuGC animals from postnatal day 3. (**e**) Conversely, AChE mRNA levels are decreased at postnatal day 90 (n~CTR~ = 4; n~iuGC~ = 5). (**f**) Representative immunoblot of ChAT and AChE in the LDT of 3, 30 and 90 days old animals. (**g**) Protein quantification confirmed the upregulation of ChAT and (**h**) downregulation of AChE in the LDT from postnatal day 3 until adulthood (n~CTR~ = 4; n~iuGC~ = 5). Data represented as mean ±s.e.m. \*p\<0.05, \*\*p\<0.001, \*\*\*p\<0.0001. Scale bars in b: 100 µm and inset - 50 µm. Additional data is depicted in [Figure 1---figure supplements 1](#fig1s1){ref-type="fig"}, [2](#fig1s2){ref-type="fig"} and [3](#fig1s3){ref-type="fig"}.](elife-25843-fig1){#fig1}

We next evaluated gene and protein expression levels of ChAT and AChE in the LDT ([Figure 1d--h](#fig1){ref-type="fig"}). We found a significant effect of iuGC treatment in ChAT (Two-way ANOVA; F~(1,24)~ = 26.27, p\<0.0001) and AChE (Two-way ANOVA; F~(1,23)~ = 15.71, p=0.0006) gene expression. ChAT gene expression levels were increased at 3 and 30 days of age in iuGC animals ([Figure 1d](#fig1){ref-type="fig"}; *post-hoc* Bonferroni; CTR~(3\ days)~ vs. iuGC~(3\ days)~: t~(24)~ = 3.383, p=0.0074; CTR~(30\ days)~ vs. iuGC~(30\ days)~: t~(24)~ = 3.053, p=0.0164; CTR~(90\ days)~ vs. iuGC~(90\ days)~: t~(24)~ = 2.494, p=0.059). Decreased AChE levels were found in adult iuGC animals ([Figure 1e](#fig1){ref-type="fig"}; *post-hoc* Bonferroni; CTR~(3\ days)~ vs. iuGC~(3\ days)~: t~(23)~ = 1.24, p=0.6827; CTR~(30\ days)~ vs. iuGC~(30\ days)~: t~(23)~ = 2.244, p=0.1043; CTR~(90\ days)~ vs. iuGC~(90\ days)~: t~(23)~ = 3.298, p=0.0094). We also evaluated the levels of another cholinergic marker, the vesicular acetylcholine transporter (VAChT) and found that mRNA levels were unchanged between groups in the LDT ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).

Two-way ANOVA showed a significant effect of iuGC treatment in ChAT (F~(1,23)~ = 32.82, p\<0.0001) and AChE protein expression (F~(1,18)~ = 425.08, p\<0.0001). Western blot analysis confirmed the upregulation of ChAT ([Figure 1f--g](#fig1){ref-type="fig"}; *post-hoc* Bonferroni; CTR~(3\ days)~ vs. iuGC~(3\ days)~: t~(23)~ = 4.401, p=0.0006; CTR~(30\ days)~ vs. iuGC~(30\ days)~: t~(23)~ = 2.762, p=0.0333; CTR~(90\ days)~ vs. iuGC~(90\ days)~: t~(23)~ = 2.712, p=0.0373); and downregulation of AChE in the iuGC group at all ages tested ([Figure 1f and h](#fig1){ref-type="fig"}; *post-hoc* Bonferroni; CTR~(3\ days)~ vs. iuGC~(3\ days)~: t~(18)~ = 4.73, p=0.0005; CTR~(30\ days)~ vs. iuGC~(30\ days)~: t~(18)~ = 3.157, p=0.0164; *post-hoc* Bonferroni CTR~(90\ days)~ vs. iuGC~(90\ days)~: t~(18)~ = 3.349, p=0.0107).

Considering the heterogeneous nature of LDT inputs to the VTA, we also assessed the impact of iuGC exposure on glutamatergic and GABAergic markers ([Figure 1---figure supplement 3a--c,e--g](#fig1s3){ref-type="fig"}). Gene and protein expression levels of glutamate transporter EAAC1 and GAD1/67 + GAD2/65 were not significantly affected by iuGC exposure.

We also decided to evaluate the expression levels of glucocorticoid receptor (GR) since early life adversity has been shown to change GR epigenetic status. We found no differences between groups regarding GR expression ([Figure 1---figure supplement 3d,h](#fig1s3){ref-type="fig"}).

iuGC treatment impairs the LDT-VTA circuitry {#s2-2}
--------------------------------------------

Previous work from our group showed that iuGC animals presented a VTA-NAc hypodopaminergic state ([@bib30]; [@bib11]; [@bib52]). Since the LDT innervates the VTA and can influence NAc dopamine release ([@bib9]; [@bib8]; [@bib19]; [@bib21]; [@bib35]; [@bib20]), we decided to characterize the LDT-VTA circuit using *in vivo* single cell electrophysiology in anesthetized animals ([Figure 2](#fig2){ref-type="fig"}).

![Distinct VTA neuronal response to LDT electrical stimulation in iuGC animals.\
(**a**) Schematic representation of the *in vivo* single-cell electrophysiological recording experiments and electrode placement in the LDT in anesthetized animals. (**b**) iuGC animals present decreased basal activity of LDT neurons in comparison to CTR (n~LDT-CTR~ = 36 cells; n~LDT-iuGC~ = 94 cells). (**c**) Schematic representation of the *in vivo* single-cell electrophysiological recording experiments in the VTA with electric stimulation performed in the LDT; and recording electrode placement. (**d**) The basal activity of the VTA is similar between groups (n~VTA-CTR~ = 40 cells; n~VTA-iuGC=~32 cells). (**e**) Electrical stimulation of the LDT (0.5 Hz) induces excitatory and inhibitory responses in VTA neurons. Pie plots represent the percentage of excitatory, inhibitory and no responses of VTA neurons. (**e--g**) In CTR animals, 50% of neurons present an excitatory response (70% pDAergic, 20% pGABAergic) and 30% present an inhibitory response (21% pDAergic, 50% pGABAergic). iuGC group shows a different profile, with 31% of recorded cells presenting an excitatory response (30% pDAergic, 60% pGABAergic) versus 44% with inhibitory response (57% pDAergic, 29% pGABAergic). (**f**) Representative examples of rat VTA pDAergic and pGABAergic neuronal waveforms. (**g**) Firing rate and waveform duration were used to classify single units into 3 types of neurons. (**h**) Percentage of each putative neuronal population presenting excitation, inhibition or with no response to LDT stimulation. There is a shift in the percentage of putative DAergic and GABAergic neurons presenting excitatory and inhibitory responses. Numbers in bars represent number of cells in each category. (**i, m**) Peristimulus time histograms (PSTHs) show LDT-evoked responses of VTA dopamine neurons; (**i**) excitation; (**m**) inhibition. (**j**) VTA neurons that display an excitatory profile in response to LDT electrical stimulus present increased latency to fire in iuGC animals. (**k**) The magnitude and (**l**) duration of response of VTA neurons is reduced in iuGC animals. (**n**) VTA neurons that display an inhibitory response in response to LDT electrical stimulus do not show differences in the latency to fire in both groups. (**o**) The magnitude of response of inhibited neurons of the VTA is increased in iuGC animals, with no differences in (**p**) the duration of inhibition in VTA neurons upon LDT stimulation. pDAergic: putative dopaminergic neurons; pGABAergic: putative GABAergic neurons. Data is represented as mean ±s.e.m. \*p\<0.05, \*\*p\<0.001, \*\*\*p\<0.0001.](elife-25843-fig2){#fig2}

iuGC treatment significantly decreased the spontaneous activity of LDT neurons ([Figure 2a--b](#fig2){ref-type="fig"}; t~(128)~ = 4.674, p\<0.0001, total number of cells: CTR = 36, iuGC = 94; n~CTR~ = 8, n~iuGC~ = 11 animals). No differences were found in the basal activity of VTA ([Figure 2c--d](#fig2){ref-type="fig"}; t~(70)~ = 0.0576, p=0.9542, total number of cells: CTR = 40, iuGC = 32; animals: CTR = 8, iuGC = 11).

Electrical stimulation at 0.5 Hz of the LDT evoked both excitatory and inhibitory responses in VTA neurons in contrasting percentages ([Figure 2e](#fig2){ref-type="fig"}; CTR: 50% excitatory and 30% inhibitory; iuGC: 31% excitatory and 44% inhibitory). We also used defined criteria based on extracellular waveforms and firing rate ([@bib60]; [@bib59]; [@bib57]) to divide recorded cells into putative DAergic (pDAergic) or GABAergic (pGABAergic) neurons ([Figure 2f--h](#fig2){ref-type="fig"}). Cells that did not match these criteria were considered to be 'other' types of neurons.

Interestingly, iuGC animals present a shift in the type of neurons that present excitatory responses, with an increase in pGABAergic neurons and concomitant decrease in pDAergic neurons. Excitatory responses were observed in 70% of pDAergic and 20% of pGABAergic neurons in CTR animals versus 30% of pDAergic and 60% of pGABAergic neurons in iuGC animals.

Regarding inhibition, the iuGC group presented an increase in pDAergic neurons together with a decrease in pGABAergic neurons ([Figure 2h](#fig2){ref-type="fig"}). Briefly, inhibitory responses were observed in 21% of pDAergic and 50% of pGABAergic neurons in CTR animals versus 57% of pDAergic and 28% of pGABAergic neurons in iuGC animals.

The onset of excitation was significantly increased in iuGC group in comparison to control group ([Figure 2j](#fig2){ref-type="fig"}; CTR: 0.45 ± 0.114 ms vs. iuGC: 9.33 ± 2.49 ms; t~(30)~ = 4.637, p\<0.0001). Interestingly, iuGC treatment reduced the magnitude and duration of the excitatory response ([Figure 2k--l](#fig2){ref-type="fig"}; magnitude: t~(30)~ = 3.723, p=0.0008; duration: t~(30)~ = 2.196, p=0.0360).

LDT stimulation did not affect the latency of inhibition, although there was a trend for increased latency in iuGC animals ([Figure 2n](#fig2){ref-type="fig"}; CTR: 11.58 ± 3.175 ms vs. iuGC: 18.61 ± 4.979 ms; t~(28)~ = 1.057, p=0.2997). Also, the duration of response was not affected ([Figure 2p](#fig2){ref-type="fig"}; t~(28)~ = 1.510, p=0.1422). However, the response magnitude of inhibitory responses in the VTA evoked by LDT electrical stimulation was significantly higher in iuGC animals ([Figure 2o](#fig2){ref-type="fig"}; t~(28)~ = 2.905, p=0.0071).

Altogether, this data demonstrated an imbalance in the excitatory and inhibitory inputs to the VTA when electrically stimulating the LDT.

Optogenetic activation of LDT terminals in the VTA elicits distinct responses in control and iuGC animals {#s2-3}
---------------------------------------------------------------------------------------------------------

We next used a combined viral approach to specifically modulate LDT direct inputs to the VTA and exclude the effects of indirect activation of other regions to where LDT projects to. We decided to activate all types of LDT-VTA inputs (and not only cholinergic) because we observed an effect of iuGC exposure in both excitatory and inhibitory VTA responses elicited by LDT activation.

To do so, we injected a viral vector containing a WGA--Cre fusion construct (AAV5--EF1a--WGA--Cre--mCherry) in the VTA, and a cre-dependent ChR2 vector in the LDT (AAV5-EF1a-DIO-hChR2-eYFP). The WGA--Cre fusion protein is retrogradely transported ([@bib23]), inducing the expression of cre-dependent ChR2-YFP only in LDT neurons that directly project to the VTA ([Figure 3a--c](#fig3){ref-type="fig"}). Four weeks post-injection, we observed YFP staining in axonal terminals of LDT neurons in the VTA ([Figure 3b](#fig3){ref-type="fig"}) and in cell bodies in the LDT ([Figure 3c](#fig3){ref-type="fig"}).

![Optogenetic activation of LDT terminals in VTA elicits a differential electrophysiological response in iuGC animals.\
(**a**) Strategy used for optogenetic activation of LDT projecting neurons in the VTA. An AAV5--EF1a--WGA--Cre--mCherry virus construct was injected unilaterally in the VTA, and a cre-dependent ChR2 vector (AAV5-EF1a-DIO-hChR2-eYFP) in the LDT. WGA-Cre will retrogradely migrate and induce the expression of ChR2 in LDT neurons that directly project to the VTA. (**b**) Representative image of immunofluorescence for GFP showing LDT axon terminals in the VTA and (**c**) cell bodies in the LDT; scale bar: 200 µm. (**d**) Optogenetic stimulation of LDT terminals in the VTA (blue rectangle; 30 pulses of 15 ms at 20 Hz) increases the firing rate of VTA neurons in both groups (n~CTR~ = 72 cells; n~iuGC~ = 82 cells). (**e**) In CTR, upon LDT terminal stimulation, 48% of recorded VTA cells present an increase in firing rate (of those 69% pDAergic, 17% pGABAergic), 21% decrease activity (0% pDAergic, 87% pGABAergic) and 31% presented no change. In iuGC animals, upon LDT terminal stimulation, 44% of recorded VTA cells present an increase in firing rate (83% pDAergic; 11% GABAergic) 27% decrease activity (55% pGABAergic, 36% DAergic) and 29% presented no change. (**f**) Firing rate and waveform duration were used to classify single units into 3 types of neurons. (**g**) Percentage of each putative neuronal population presenting excitation, inhibition or with no response to LDT terminals optogenetic stimulation. Numbers in bars represent number of cells in each category. pDAergic: putative dopaminergic neurons; pGABAergic: putative GABAergic neurons. Data represented as mean ±s.e.m. \*\*\*p\<0.001. Additional data is depicted in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.](elife-25843-fig3){#fig3}

We performed *in vivo* single cell electrophysiology in the VTA while stimulating LDT terminals in this region, in order to activate the LDT-VTA circuit specifically. As depicted in [Figure 3d](#fig3){ref-type="fig"}, optogenetic stimulation of LDT terminals (30 pulses of 15 ms at 20 Hz) induced an increase in firing rate of VTA neurons ([Figure 3d](#fig3){ref-type="fig"}, *post-hoc* Bonferroni test CTR-ChR2: baseline vs. stimulus - t~(118)~ = 5.883, p\<0.0001, stimulus vs. post-stimulus - t~(118)~ = 3.749, p=0.0008; iuGC-ChR2: baseline vs. stimulus - t~(118)~ = 10.99, p\<0.0001; stimulus vs. post-stimulus - t~(118)~ = 10.88, p\<0.0001), eliciting a response in 69% and 71% of recorded cells of CTR and iuGC animals, respectively ([Figure 3e](#fig3){ref-type="fig"}). Optic stimulation did not affect the latency of stimulus response for the groups ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).

In CTR animals, 49% of cells presented increased firing rate upon stimulation, and of these, 69% were pDAergic, 17% pGABAergic and 14% were categorized as 'other' neuronal subtypes. Moreover, 87% of cells that presented inhibitory responses were pGABAergic neurons ([Figure 3f--g](#fig3){ref-type="fig"}). In iuGC animals, 44% of cells presented increased firing rate upon stimulation, and the majority were pDAergic neurons (83%). Surprisingly, and clearly different from CTR animals, 55% of cells that presented inhibitory responses were pDAergic neurons and 36% were considered to be pGABAergic neurons ([Figure 3g](#fig3){ref-type="fig"}). Again, and in accordance with the electrical stimulation data, our optogenetic results suggest an imbalance in the excitatory and inhibitory inputs from the LDT to the VTA.

Activation of LDT terminals in the VTA rescues motivational deficits of iuGC animals {#s2-4}
------------------------------------------------------------------------------------

Since the LDT-VTA circuitry has been described to contribute for positive reinforcement ([@bib29]; [@bib54]; [@bib28]), we evaluated the motivational drive by testing willingness to work for food in a progressive ratio (PR) schedule of reinforcement. This test measures the breakpoint or maximum effort rats are willing to perform for an outcome, when the demand grows progressively over a session.

Training was similar between CTR, CTR-YFP, CTR-ChR2 and iuGC-ChR2 groups across days either in the continuous reinforcement (CRF) or fixed ratio (FR) sessions ([Figure 4---figure supplement 1a--b](#fig4s1){ref-type="fig"}). In the test day, iuGC-ChR2 rats presented a significant decrease in breakpoint in comparison to CTR, CTR-YFP and CTR-ChR2 animals ([Figure 4a](#fig4){ref-type="fig"}; 48,9% decrease; *post-hoc* Bonferroni test CTR vs. iuGC-ChR2: t~(68)~ = 2.882, p=0.0317; CTR-YFP vs. iuGC-ChR2: t~(68)~ = 2.78, p=0.0421; CTR-ChR2 vs. iuGC-ChR2: t~(68)~ = 4.141, p=0.0006), with no differences in the number of pellets earned during the test ([Figure 4---figure supplement 1c](#fig4s1){ref-type="fig"}).

![Optogenetic activation of LDT-VTA rescues motivational deficits of iuGC-ChR2 animals and induces conditioning.\
(**a**) Optogenetic stimulation of LDT terminals in the VTA during cue exposure (30 pulses of 15 ms at 20 Hz) rescues the breakpoint deficits in the PR test of iuGC-ChR2 animals, with no effect in other groups (n~CTR~ = 6; n~CTR-eYFP~ = 7; n~CTR-ChR2~ = 13; n~iuGC-ChR2~ = 12). (**b**) Activation of LDT terminals in the VTA in an *irrelevant* period, such as for example during inter-trial interval (ITI) does not change breakpoint of iuGC-ChR2 animals. (**c**) Individual performance in the PR test. All iuGC-ChR2 animals increase their breakpoint when stimulation is associated with the cue but not during the ITI. (**d**) Schematic representation of the CPP protocol. Laser stimulation (30 pulses of 15 ms at 20 Hz, every 60 s) is associated to one chamber. (**e**) Optogenetic stimulation of LDT terminals in the VTA increases preference for the stimulation-paired box (ON) in iuGC-ChR2 but not in CTR-eYFP nor CTR-ChR2 animals (n~CTR~ = 6; n~CTR-eYFP~ = 7; n~CTR-ChR2~ = 5; n~iuGC-ChR2~ = 6). (**f**) Difference score of CPP protocol shown as the difference in time spent in pre- and post-test. iuGC-ChR2 animals present a shift in preference for the ON chamber. (**g**) Real Time Place Preference (RTPP) protocol: animals were placed in a box with two identical chambers for 15 min and allowed to freely explore. When animals crossed to the ON side, optical stimulation was given until exiting the chamber. Shown are representative tracks from a CTR, CTR-eYFP, CTR-ChR2 and an iuGC-ChR2 animal. (**h**) CTR-ChR2 and iuGC-ChR2 rats spend a significantly higher percentage of time in the stimulation-associated box (ON side) (n~CTR~ = 6; n~CTR-eYFP~ = 7; n~CTR-ChR2~ = 8; n~iuGC-ChR2~ = 6). (**i**) Difference between time spent in the ON versus OFF side. Data represented as mean ±s.e.m. \*p\<0.05, \*\*p\<0.001, \*\*\*p\<0.0001. \#: comparison with CTR-eYFP; +: comparison with CTR-ChR2. Additional data is depicted in [Figure 4---figure supplements 1](#fig4s1){ref-type="fig"}--[3](#fig4s3){ref-type="fig"}.](elife-25843-fig4){#fig4}

We next assessed if selective optogenetic activation of the LDT-VTA pathway was sufficient to enhance motivation during the PR test session. We decided to stimulate animals during cue exposure period since previous work from our group suggested that iuGC animals presented deficits in the Pavlovian-to-Instrumental Transfer test (PIT) ([@bib52]; [@bib53]), which measures the ability of a Pavlovian conditioned stimulus that is associated with a reward to invigorate instrumental responding for that (or other) reward ([@bib14]; [@bib15]; [@bib25]).

Activation of LDT terminals in the VTA during cue exposure period (30 pulses of 15 ms at 20 Hz; around 15 stimulations per session) reverted the breakpoint of iuGC animals but had no effect in CTR, CTR-eYFP and CTR-ChR2 animals ([Figure 4a--c](#fig4){ref-type="fig"}; *post-hoc* Bonferroni test CTR: t~(34)~ = 0.1836, p\>0.9999; CTR-ChR2: t~(34)~ = 1.203, p=0.9498; CTR-eYFP: t~(34)~ = 0.5099, p\>0.9999; iuGC-ChR2: t~(34)~ = 5.007, p\<0.0001;). No effect was observed in the number of pellets earned ([Figure 4---figure supplement 1c](#fig4s1){ref-type="fig"}). Moreover, no effects in locomotion or free feeding consumption were observed using the same stimulation parameters in either group ([Figure 4---figure supplement 1e--f](#fig4s1){ref-type="fig"}).

Importantly, if the LDT-VTA optogenetic activation occurred during the inter-trial interval (ITI) period of the test session, it did not revert iuGC-ChR2 motivational deficits ([Figure 4b--c](#fig4){ref-type="fig"}; *post-hoc* Bonferroni: t~(34)~ = 0.5138, p\>0.9999), suggesting that LDT-VTA activation elicits a positive behavioral response only when it occurs during specific periods of the test.

Because the results of control animals were surprising in the light of previous evidence showing that LDT-VTA stimulation was reinforcing ([@bib29]; [@bib67]), we performed another stimulation protocol in a new set of animals to test this hypothesis (80 pulses of 15 ms at 20 Hz) ([Figure 4---figure supplement 2a--b](#fig4s2){ref-type="fig"}). Importantly, when we increased the number of pulses, we observed an increase in the breakpoint of CTR-ChR2 animals (*post-hoc* Bonferroni: t~(22)~ = 3.666, p=0.0054) when compared to breakpoint of CTR or CTR-eYFP animals (*post-hoc* Bonferroni CTR-ChR2 vs. CTR: t~(44)~ = 3.075, p=0.0217; CTR-ChR2 vs. CTR-eYFP: t~(44)~ = 3.194, p=0.0156). Additionally, we observed that this stimulation also increased the breakpoint of iuGC animals (*post-hoc* Bonferroni: t~(22)~ = 4.641, p=0.0005), with no effect in CTR and CTR-eYFP groups (*post-hoc* Bonferroni CTR: t~(22)~ = 0.116, p\>0.9999; CTR-eYFP: t~(22)~ = 0.4163, p\>0.9999).

Stimulation of LDT-VTA terminals induces place preference {#s2-5}
---------------------------------------------------------

To get further insight on the role of the LDT-VTA circuit in behavior, we also evaluated the impact of the stimulation of LDT-VTA terminals in the conditioned place preference (CPP) test, which measures the reinforcing capacities of a particular stimulus ([Figure 4d](#fig4){ref-type="fig"}). LDT-VTA stimulation (30 pulses of 15 ms at 20 Hz every 60 s) elicited conditioning in iuGC group, given by increased preference for the stimulus-associated chamber, ON side, ([Figure 4e--f](#fig4){ref-type="fig"}; *post-hoc* Bonferroni: t~(20)~ = 5.892, p\<0.0001), whereas it did not shift preference in CTR and CTR-eYFP animals.

However, if we increase the number of stimulus (80 pulses of 15 ms every 15 s), we were able to induce conditioning in CTR-ChR2 animals ([Figure 4---figure supplement 2c](#fig4s2){ref-type="fig"}; t~(8)~ = 4.737, p=0.0015). Additionally, we observe the same effect in the iuGC-ChR2 group ([Figure 4---figure supplement 2d](#fig4s2){ref-type="fig"}; *post-hoc* Bonferroni CTR-ChR2: t~(23)~ = 3.576, p=0.0064; iuGC-ChR2: t~(23)~ = 2.761, p=0.044). No effect was found in CTR and CTR-eYFP animals, as expected (*post-hoc* Bonferroni CTR: t~(23)~ = 0.04378, p\>0.9999; CTR-eYFP: t~(23)~ = 0.1521, p\>0.9999).

In order to further explore the reinforcing feature of LDT-VTA stimulation, we performed the real-time place preference test (RTPP; [Figure 4g](#fig4){ref-type="fig"}), where one chamber is paired with optical stimulation and the other is not. Every time the animal was in the designated stimulation box (ON side), it received optical stimulation (15 ms pulses at 20 Hz) that only ended when the animal crossed to the no-stimulation box (OFF side). This test is different from a classic CPP since the animal is able to choose the chamber throughout the test.

We observed that stimulation of LDT terminals in the VTA was sufficient to elicit preference for the stimulation-paired chamber in both CTR-ChR2 and iuGC-ChR2 groups ([Figure 4h](#fig4){ref-type="fig"}; *post-hoc* Bonferroni CTR-ChR2: t~(23)~ = 8.212, p\<0.0001; iuGC-ChR2 t~(23)~ = 8.748, p\<0.0001) with no effect on control groups (CTR and CTR-eYFP) (*post-hoc* Bonferroni CTR: t~(23)~ = 0.1981, p\>0.9999; CTR-eYFP: t~(23)~ = 1.784, p\>0.9999). Both CTR-ChR2 and iuGC-ChR2 groups spent significantly more time in the ON side as assessed by the difference of total time spent in each chamber ([Figure 4i](#fig4){ref-type="fig"}; *post-hoc* Bonferroni CTR-ChR2 vs. CTR: t~(23)~ = 5.451, p=0.0001; CTR-ChR2 vs. CTR-eYFP: t~(23)~ = 4.562, p=0.0008; iuGC-ChR2 vs. CTR: t~(23)~ = 5.387, p\<0.0001; iuGC-ChR2 vs. CTR-eYFP: t~(23)~ = 4.543, p=0.0009).

Discussion {#s3}
==========

Here we show that prenatal exposure to GCs alters the number of ChAT^+^ cells and induces long-lasting expression changes on cholinergic markers (ChAT and AChE) in the LDT, but had no effect on glutamatergic or GABAergic markers. These findings are particularly interesting because both ChAT and AChE contain a glucocorticoid response element (GRE) in their gene *loci*, pinpointing a direct transcriptional regulation by GCs ([@bib18]; [@bib22]; [@bib26]; [@bib7]; [@bib2]), although this remains to be confirmed. In fact, it has been shown that stress changes cholinergic enzymes expression ([@bib18]; [@bib27]), either by inducing an alternative splicing of AChE gene ([@bib38]), or by modulating the epigenetic status of its promoter regions ([@bib49]). These cholinergic changes observed in iuGC group are more likely to derive from a new equilibrium set *in utero* by GC exposure rather than by changes in the hypothalamic--pituitary--adrenal (HPA) axis, since in adulthood iuGC animals present normal basal levels of corticosterone ([@bib9]).

Importantly, this GC *programming effect* in gene expression has been previously demonstrated for other circuits. For example, GC-exposed animals displayed differential methylation status of dopamine receptor D2 promoter region, accompanied by long-lasting gene/protein expression changes in the NAc ([@bib47]). These results show that a brief exposure to GC during critical developmental periods may induce persistent effects in specific genes, which may contribute for the increased vulnerability for emotional disorders observed in early life stress models ([@bib11]; [@bib12]; [@bib45]; [@bib36]).

We also found that the LDT presents decreased basal neuronal activity, and that LDT electrical stimulation produces a differential response in the VTA of iuGC animals. Indeed, iuGC group presented a decrease in the magnitude and duration of excitatory responses in the VTA, and inversely, the inhibitory response was increased, suggesting that the function of the LDT-VTA pathway was compromised. To our knowledge, this is the first report showing electrophysiological differences in the LDT-VTA circuitry induced by GCs. The latency of excitatory responses in the VTA upon LDT electrical (or optogenetic) stimulation in control animals was remarkably low, but we were unable to find any electrophysiological studies to compare to.

Importantly, the latency of VTA excitatory responses to LDT electrical stimulation was substantially increased in iuGC animals. A combination of pre- and post-synaptic iuGC-induced changes may contribute for this phenomenon, however, because this delay is not observed upon optical excitation of LDT-VTA terminals, it pinpoints to changes in axonal conductivity. Additional studies are now needed in order to understand how GC induces these long-lasting electrophysiological changes.

The VTA contains around 65% of DAergic neurons and 35% of non-DAergic neurons ([@bib37]), being the latter mainly GABAergic, though subpopulations of glutamatergic neurons as well as dopamine/glutamate co-releasing neurons have been identified ([@bib68]; [@bib24]). Considering this, we sub-divided the VTA recorded cells into putative DAergic and GABAergic neurons based on their waveform pattern ([@bib60]; [@bib59]; [@bib57]), yet, it is important to refer that there is still some controversy regarding this categorization ([@bib32]). Importantly, Omelchenko and colleagues suggested that the LDT mediates a divergent excitation/inhibition influence on mesoaccumbens neurons that is likely to excite DAergic cells and inhibit GABA neurons of this region ([@bib42]; [@bib43]); which is in accordance with our data in control animals.

The LDT provides the tonic input necessary for maintaining burst firing of DAergic neurons ([@bib31]) and dopamine release to the NAc ([@bib8]; [@bib19]), contributing to reward behaviors ([@bib29]; [@bib54]; [@bib67]). In fact, phasic activation of VTA DAergic neurons can induce behavioral conditioning ([@bib58]) and facilitate positive reinforcement ([@bib1]; [@bib65]). Conversely, VTA GABAergic neurons provide local inhibition of DAergic neurons (but also long-range inhibition of projection regions, including the NAc), and their activation disrupts reward consummatory behavior ([@bib61]). Surprisingly, in iuGC animals we observe a shift in the LDT-VTA evoked responses: an increase of inhibition of DAergic neurons and simultaneous decrease of inhibition of GABAergic neurons. This suggests that VTA DAergic neurons are less active, which is in accordance with the observed decreased basal levels of dopamine in the NAc of iuGC animals ([@bib30]; [@bib47]).

Confirming the functional relevance of the abovementioned electrophysiological data, we have previously shown that iuGC animals exhibited impaired cue-driven motivational drive ([@bib52]; [@bib53]). In line with this, we found that iuGC animals presented significant motivational deficits in the PR test. Remarkably, brief optogenetic activation of LDT-VTA terminals during cue exposure was sufficient to rescue the motivation of iuGC animals, with no major impact on control animals, proving that iuGC exposure induces changes in this circuit that are translated into motivational deficits. However, when LDT-VTA stimulation was done during the time-out period of the test, it did not induce any behavioral effect, reinforcing the importance of specific time windows for the stimulation. To our knowledge, this is the first report showing a role of the LDT-VTA circuit in the control of cue-induced motivation. It is important to refer that we decided to use a strategy that activates all LDT inputs because although the majority of its neurons are cholinergic, there are also glutamatergic and GABAergic neurons in the LDT ([@bib67]; [@bib63]), and each provide parallel sources of input to the VTA. Certainly, additional studies are needed to dissect and evaluate the contribution of each LDT neuronal population for this type of behaviors.

To further understand the role of LDT-VTA in reward behaviors, we tested the animals in two different conditioning paradigms, the non-contingent CPP and the contingent RTPP. Activation of LDT-VTA specific projections shifts animal's preference for the stimulus-associated chamber in both tests. However, iuGC animals seem more susceptible to these reinforcing effects because a *lower stimulation* protocol (30 pulses of 15 ms at 20 Hz) was able to shift iuGC group preference but had no effect in control animals. Importantly, this vulnerability to rewarding/reinforcing stimulus is in accordance with previous data from our team showing that iuGC animals presented increased morphine-associated CPP in comparison to controls ([@bib47]). It is thus tempting to speculate that the increased vulnerability of iuGC animals to the effects of LDT-VTA stimulation is due to an imbalance in the excitation-inhibition responses in the VTA triggered by LDT inputs.

In summary, iuGC exposure leads to long-lasting molecular and physiological alterations in the LDT-VTA circuit in parallel with prominent motivational deficits, which were rescued by optogenetic activation of the LDT-VTA terminals. Moreover, we showed that activation of LDT-VTA inputs is reinforcing and that iuGC animals appear to be more vulnerable to the reinforcing properties of this stimulus. Further studies are now needed to identify how GCs lead to functional changes in vulnerable regions such as the LDT and how this translates into altered behavior.

Materials and methods {#s4}
=====================

Animals and treatments {#s4-1}
----------------------

Pregnant Wistar rats were individually housed under standard laboratory conditions (light/dark cycle of 12/12 hr; 22°C); food and water *ad libitum*. Subcutaneous injections of a synthetic GC, dexamethasone (DEX, Sigma, Germany) at 1 mg kg^−1^ (iuGC animals) or vehicle (sesame oil, Sigma, Germany; CTR- control animals) were administered on gestation days 18 and 19 (details of the model can be found in [@bib30]; [@bib11]; [@bib52]; [@bib47]; [@bib12]; [@bib9]). This model, named iuGC (from *in utero* exposure to GCs) partially mimics the clinical administration of GCs on women in risk of preterm labour (\~8% of pregnancies) to promote fetal lung maturation or to manage congenital adrenal hyperplasia during pregnancy. On postnatal day 21, progeny was weaned according to prenatal treatment and gender. Male offspring derived from at least 4 different litters were used.

All manipulations were conducted in strict accordance with European Regulations (European Union Directive 2010/63/EU). Animal facilities and the people directly involved in animal experiments were certified by the Portuguese regulatory entity -- DGAV. All the experiments were approved by the Ethics Committee of the University of Minho (SECVS protocol \#107/2015). The experiments were also authorized by the national competent entity DGAV (\#19074).

Macrodissection and molecular analysis {#s4-2}
--------------------------------------

Rats were anaesthetized with sodium pentobarbitone (Eutasil, Sanofi, CEVA, Algés, Portugal), decapitated, and heads were immediately snap-frozen in liquid nitrogen. Brain areas of interest were rapidly dissected on ice under a magnifier following specific anatomical landmarks ([@bib44]).

For real-time PCR analysis, total RNA was isolated from samples using Trizol (Invitrogen, Carlsbad, CA, USA) and treated using DNase (Fermentas, Burlington, Canada) according to the manufacturer's instructions. cDNA was synthetized using the iSCRIPT kit (Biorad, Hercules, CA, USA). PCR was performed using EVAGreen SMX (Biorad, Hercules, CA, USA) and the Biorad q-PCR CFX96 apparatus (Biorad, Hercules, CA, USA). *Hprt* was used as housekeeping gene. Relative quantification was used to determine fold changes (control vs. iuGC), using the ΔΔCT method.

Primer sequences used for transgene expression quantification were:

ChAT: Forward, 5'-TCATTAATTTCCGCCGTCTC-3', Reverse, 5'-CCGGTTGGTGGAGTCTTTTA-3'; AChE: Forward, 5'-CCAGAGACAGAGGACATTCTGA-3', Reverse, 5'-GCGTTCCTGCTTGCTATAGTG-3'; VAChT: Forward, 5'-AGTGCCTACTTGGCCAACAC-3', Reverse, 5'-GTCGTAGCTCATGCGATCAA-3'; EAAC1; Forward, 5'-CATCCCTCATCCCACATCCG-3', Reverse, 5'-CTACCACGATGCCCAGTACC-3'; GAD1/Gad67: Forward, 5'- GCTCCCTGTGGCTGAATCG-3', Reverse, 5'- GTCCTTTGCAAGAAACCACAG-3'; GAD2/Gad65: Forward, 5'-CTGGCTTTTGGTCCTTCGGA-3', Reverse, 5'-AGCAGAGCGCATAGCTTGTT-3'; GR: Forward, 5'- AGGCCGGTCAGTGTTTTCT-3', Reverse, 5'-CAATCGTTTCTTCCAGCACA-3'.

For western blotting analysis, samples were prepared as previously described ([@bib47]). 30 μg of the protein was run in SDS-polyacrylamide gel and then transferred to nitrocellulose membranes. Membranes were incubated with one of the primary antibodies: goat anti-choline acetyltransferase (ChAT, 1:500, Millipore, MA, USA), goat anti-acetylcholine esterase (AChE, 1:500, Abcam, Cambridge, UK), mouse anti-glutamate transporter, excitatory amino-acid transporter, EAAC1 (EAAC1, 1:200, Millipore, MA, USA), rabbit anti-glutamic acid decarboxylase (GAD) 65 + GAD 67 (GAD65/67, 1:10000, Abcam, Cambridge, UK), rabbit anti-glucocorticoid receptor (GR, 1:500, Santa Cruz, CA, USA) and mouse anti-GAPDH (1:200, Iowa, USA) or mouse anti-beta actin (1:2500, Abcam, Cambridge, UK) were used as loading controls for ChAT or AChE, and EAAC1, GAD65/67 or GR, respectively. The secondary antibodies were incubated at a 1:10000 (anti-mouse), 1:5000 (anti-rabbit) and 1:7500 (anti-goat) dilution (Santa Cruz Biotechnologies, Santa Cruz, CA, USA). Membranes were stripped for 15 min at room temperature in stripping buffer (Restore PLUS Western Blot Stripping Buffer, Thermo Scentific, IL, USA) and re-blocked and re-incubated. Detection was performed using ECL kit (Biorad, Hercules, CA, USA) and bands were quantified using ImageJ (<http://rsbweb.nih.gov/ij/>).

Immunohistochemistry (IHC) {#s4-3}
--------------------------

Animals were anaesthetized with sodium pentobarbitone (Eutasil, Lisbon, Portugal) and transcardially perfused with saline followed by 4% paraformaldehyde. Brains were removed and sectioned coronally at a thickness of 50 μm, on a vibrating microtome (VT1000S, Leica, Germany).

Free-floating sections were pre-treated with 3% H~2~O~2~ in PBS for 30 min. After blocking using 2.5% fetal bovine serum (FBS) in PBS-Triton 0.3% for 2 hr at room temperature, sections were incubated overnight at 4°C with primary antibody anti-ChAT (1:1000; Millipore, MA, USA). Afterwards, sections were washed and incubated with the secondary polyclonal swine anti-goat biotinylated antibody (1:200, DAKO, Denmark) for 1 hr, and processed with an avidin-biotin complex solution (ABC-Elite Vectastain reagent; Vector Lab., USA) and detected with 0.5 mg ml^−1^ 3,3´-diaminobenzidine (Sigma, Germany) including 12.5 µl of 30% H~2~O~2~ as a substrate in Tris-HCL solution. Sections were washed and mounted on glass slides, air-dried, counterstained with Hematoxilin and coverslipped with Entellan (Merck, NJ, USA). Cell density estimation was obtained by normalizing ChAT^+^ cells in the corresponding area, determined using an Olympus BX51 optical microscope and the StereoInvestigator software (Microbrightfield). For each animal, 5 slices containing the LDT were used - coordinates according to Paxinos and Watson ([@bib9]). The distance of the LDT region analyzed from bregma ranged from: −8.16 mm to −9.48 mm.

In vivo electrophysiology recordings and stimulation {#s4-4}
----------------------------------------------------

Animals were anesthetized and submitted to a stereotaxic surgery for the placement of the stimulating and recording electrodes, following anatomical coordinates ([@bib44]). Surgeries were performed under sodium pentobarbitone anaesthesia (induction: 60 mg kg^−1^; maintenance: 15--20 mg kg^−1^, intraperitoneal, Eutasil, Sanofi, CEVA, Algés, Portugal); body temperature was maintained at approximately 37°C with a homoeothermic heat pad system (DC temperature controller, FHC, ME, USA). Anaesthesia level was assessed by observation of pupil size, general muscle tone and by assessing withdrawal responses to noxious pinching.

Stimulating and recording electrodes were placed in the following coordinates: LDT: −8.5 from bregma, 0.8 lateral from midline, −5.5 to −7.9 ventral to brain surface; VTA: −5.4 from bregma, 0.6 lateral from midline, −7.5 to −8.2 ventral to brain surface. A reference electrode was fixed in the skull, in contact with the dura.

Extracellular neural activity from the LDT and the VTA was recorded using a recording electrode (3--7 MΩ at 1 kHz). Recordings were amplified and filtered by the Neurolog amplifier (NL900D, Digitimer Ltd, UK) (low-pass filter at 500 Hz and high-pass filter at 5 kHz). Bi-polar concentric electrode (0.05--0.1 MΩ, Science Products) was inserted in the LDT region. Spontaneous activity of single neurons was recorded to establish baseline for at least 100 s. The stimulation was administered using a square pulse stimulator and a stimulus isolator (DS3, Digitimer, UK). The stimulation consisted of 100 pulses of 0.5 Hz with 0.5 ms duration with intensity from 0.2 to 1 mA. Spikes of a single neuron were discriminated, and data sampling was performed using a CED micro 1401 interface and SPIKE 2 software (Cambridge Electronic Design, Cambridge, UK). Single pulses were delivered to the specific brain region every 2 s. At least 100 trials were administered per cell.

For data analysis, peristimulus time histograms (PSTHs; 5 ms bin width) of neuronal activity were generated during electrical stimulation of the LDT, for each neuron recorded in the VTA. PSTHs were analysed to determine excitatory and inhibitory epochs. Briefly, the mean and standard deviation (SD) of counts per bin were determined for a baseline period, definite as the 500 ms epoch previous stimulation. The onset of excitation was defined as the first of five bins whose mean value exceeded mean baseline activity by 2 SD, and response offset was determined as the time at which activity had returned to be consistently within 2 SD of baseline. Response magnitudes for excitation were calculated with the following equation: (counts in excitatory epoch) - (mean counts per baseline bin 3 number of bins in excitatory epoch). The onset of inhibition was defined as the first of 5 bins whose mean value were below 30% of the baseline activity and the response offset when the activity of the neurons was consistently above 30% of the baseline activity. The total duration of the inhibition was determined for each neuron. We classified single units in the VTA into three separated groups of putative neurons: putative dopamine (DA), putative GABA, and 'other' neurons. This classification was based on firing rate and waveform duration (calculated from average spike waveform) ([@bib60]; [@bib59]; [@bib57]). Cells presenting a firing rate \<10.0 Hz and a duration of \>1.5 ms were considered putative DAergic (pDAergic) neurons. If the firing rate was \>10.0 Hz and waveform duration \<1.5 ms, cells were assigned to putative GABAergic (pGABAergic) neuron group. Other single units were assigned to the 'other' neuron group. This group likely contains units from both DA and GABA groups.

Regarding the experiments with optical stimulation, a recording electrode coupled with a fiber optic patch cable (Thorlabs) was placed in the VTA or LDT. The DPSS 473 nm laser system (CNI), controlled by a stimulator (Master-8, AMPI), was used for intracranial light delivery and fiber optic output was pre-calibrated to 10--15 mW. Spontaneous activity was recorded for 60 s to establish baseline activity. Optical stimulation consisted of 30 pulses of 15 ms at 20 Hz and 80 pulses of 15 ms at 20 Hz. Firing rate was calculated for the baseline, stimulation period and post stimulation period (60 s after the end of stimulation). Neurons showing a firing rate increase or decrease by more than 20% from the mean frequency of the baseline period were considered as responsive, as previously reported by Benazzouz and colleagues ([@bib4]).

At the end of each electrophysiological experiment, all brains were collected and processed to identify recording region.

Optogenetics constructs {#s4-5}
-----------------------

AAV5--EF1a--WGA--Cre--mCherry, AAV5--EF1a--DIO--hChR2--YFP and AAV5--EF1a--DIO--YFP were obtained directly from the Gene Therapy Center Vector Core (UNC) center (vectors kindly provided by Karl Deisseroth, Stanford University). AAV5 vector titers were 2.1--6.6 × 10^12^ virus molecules ml^-1^.

Surgery and cannula implantation {#s4-6}
--------------------------------

Rats designated for behavioral experiments were anesthetized with 75 mg kg^−1^ ketamine (Imalgene, Merial) plus 0.5 mg kg^−1^ medetomidine (Dorbene, Cymedica). One μl of AAV5--EF1a--WGA--Cre--mCherry was unilaterally injected into the VTA (coordinates from bregma, according to Paxinos and Watson: −5.4 mm anteroposterior, +0.6 mm mediolateral, and −7.8 mm dorsoventral) and 1 μl of AAV5--EF1a--DIO--hChR2--YFP was injected in the LDT (coordinates from bregma: −8.5 mm anteroposterior, +0.9 mm mediolateral, and −6.5 mm dorsoventral) in both CTR and iuGC groups (CTR-ChR2 and iuGC-ChR2). We had two additional groups: a control group (CTR) that was injected only with 1 μl AAV5--EF1a--DIO--hChR2--YFP in the LDT; and CTR-YFP animals which were injected with 1 μl AAV5--EF1a--WGA--Cre--mCherry in the VTA and 1 μl AAV5--EF1a--DIO--YFP in the LDT. Rats were then implanted with an optic fiber (200 μm core fiber optic; Thorlabs, NJ, USA) with 2.5 mm stainless steel ferrule (Thorlabs, NJ, USA) using the injection coordinates for the VTA (with the exception of dorsoventral: −7.7 mm) that were secured to the skull using 2.4 mm screws (Bilaney, Germany) and dental cement (C and B kit, Sun Medical). Rats were removed from the stereotaxic frame and sutured. Anaesthesia was reverted by administration of atipamezole (1 mg/kg). After surgery animals were given anti-inflammatory (Carprofeno, 5 mg/kg) for one day, analgesic (butorphanol, 5 mg/kg) for 3 days, and were let to fully recover before initiation of behavior. Optic fiber placement was confirmed for all animals after behavioral experiments ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). Animals that were assigned for electrophysiological experiments were not implanted with an optic fiber.

Behavior {#s4-7}
--------

### Progressive ratio schedule of reinforcement {#s4-7-1}

Rats were placed and maintained on food restriction (≈7 g/day of standard lab chow) to maintain 90% free-feeding weight. Behavioral sessions were performed in operant chambers (Med Associates, IL, USA) containing a central magazine that provided access to 45 mg food pellets (Bio-Serve), two retractable levers located on each side of the magazine with cue lights above them. A 2.8W, 100mA house light positioned at the top-centre of the wall opposite to the magazine provided illumination. A computer equipped with Med-PC software (Med Associates, IL, USA) controlled the equipment and recorded the data.

The behavioral protocol was previously described ([@bib53]; [@bib62]). Animals were first trained on continuous reinforcement (CRF) schedule: a single lever press yields one pellet. Side of the active lever was alternated between sessions. Rats were then trained in a fixed ratio (FR) schedule comprising 50 trials with both levers presented, but the active lever signalled by the illumination of the above cue light. When achieving the correct number of lever presses, a pellet was delivered, levers retracted and the cue light turned off for a 20 s inter-trial interval (ITI). Following up, rats were trained using an FR4 reinforcement schedule for 4 days and a FR8 for one day, for both levers. Rats were then exposed to the following schedule: day 1 -- FR4 (left lever); day 2- PR (left lever); day 3- FR4 (left lever); day 4 -- FR4 (right lever); day 5 -- PR (right lever). Food rewards were earned on an FR4 reinforcement schedule during FR sessions. PR sessions were similar to FR4 sessions except the operant requirement on each trial (T) was the integer (rounded down) of 1.4^(T--1)^ lever presses, starting at 1 lever press. PR sessions ended after 15 min without completion of the response requirement in a trial.

Before the PR session began, rats were connected to an opaque optical fiber in the VTA through previously implanted fiber optic cannula. The optical fiber was connected to a 473 nm DPSS laser (CNI Laser), controlled using a pulse generator (Master-8; AMPI). At the beginning of each trial of the PR session -- when the cue light was turned on -- animals received an optical stimulation, which consisted in 30 pulses of 15 ms at 20 Hz (473 nm; 10 mW of light at the tip of the optic fiber). In a second set of animals, the number of pulses was increased to 80 pulses of 15 ms at 20 Hz during each cue exposure. CTR, CTR-YFP, CTR-ChR2 and iuGC-ChR2 received this optical stimulation.

Conditioned place preference -- CPP {#s4-8}
-----------------------------------

The CPP protocol was adapted from a previously published report ([@bib29]; [@bib59]). Briefly, on day 1, individual rats were placed in the centre chamber and allowed to freely explore the entire apparatus for 15 min (pre-test). On day 2, rats were confined to one of the side chambers for 30 min and paired with optical stimulation, ON side; in the second session, rats were confined to the other side chamber for 30 min with no stimulation, OFF side. Conditioning sessions were counterbalanced. On day 3 rats were allowed to freely explore the entire apparatus for 15 min (post-test). Optical stimulation consisted of 30 pulses of 15 ms at 20 Hz, every 60 s. In a second set of animals optical stimulation was increased to 80 pulses of 15 ms at 20 Hz, every 15 s.

Real-time place preference -- RTPP {#s4-9}
----------------------------------

RTPP test was performed in a custom-made black plastic arena (60 × 60 × 40 cm) comprised by two indistinguishable chambers, for 15 min. One chamber was paired with light stimulation of 15 ms pulses at 20 Hz during the entire period that the animal stayed in the stimulus-paired side. The choice of paired chamber was counterbalanced across rats. Animals were placed in the no-stimulation chamber at the start of the session and light stimulation started at every entry into the paired chamber. Animal activity was recorded using a video camera and time spent in each chamber was manually assessed. Results are presented as total time spent in each chamber.

Immunofluorescence (IF) {#s4-10}
-----------------------

Animals were anaesthetized with sodium pentobarbitone (Eutasil, Lisbon, Portugal) and transcardially perfused with 0.9% saline followed by 4% paraformaldehyde. Brains were removed and sectioned coronally at a thickness of 50 μm, on a vibrating microtome (VT1000S, Leica, Germany). Sections were incubated overnight, with the primary antibody goat anti-GFP (1:500, Abcam, Cambridge, UK), followed by secondary fluorescent antibody (1:1000, Invitrogen, MA, USA). All sections were stained with 4',6-diamidino-2-phenylindole (DAPI; 1 mg ml-1) and mounted using mounting media (Permafluor, Invitrogen, MA, USA).

Statistical analysis {#s4-11}
--------------------

Statistical analysis was performed in GraphPad Prism 5.0 (GraphPad Software, Inc., La Jolla, CA, USA) and SPSS Statistics v19.0 (IBM corp., USA). Parametric tests were used whenever Shapiro-Wilk normality test SW \>0.05. Two-way analysis of variance (ANOVA) was used when appropriate. Bonferroni's post hoc multiple comparison tests were used for group differences determination. Statistical analysis between two groups was made using Student's t-test. Results are presented as mean ±SEM. Statistical significance was accepted for p\<0.05.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Impairments in laterodorsal tegmentum to VTA projections underlie glucocorticoid-triggered reward deficits\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Eric Dumont (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. The reviewers find the work interesting and relevant but raise a few important points that should be addressed. Attached are the point-by-point comments of the reviewers, but below are the more relevant issues to be addressed.

-- In the optical stimulation experiments, there should be controls for Cre expression and viral expression. The use of a Cre dependent virus expressing GFP would be advisable.

-- The article would benefit from a more detailed description and a more specific use of statistics. For example, a two-way ANOVA with age and glucocorticoid treatment as factors, followed by post-hoc tests seem more appropriate than individual t-test or Mann-Whitney tests for every age. Also, the rationale for the use or not of specific statistical tests, multiple comparison corrections, etc. should be provided.

-- Are there differences in GR expression levels in the LDT or corticosterone levels in these animals at different developmental stages that accompany the observed effects on the expression of cholinergic enzymes? Is the observed effect the result of a new equilibrium set after the in-utero treatment, or is it perpetuated through differences in GR expression or corticosterone levels?

-- The authors should specify how the loading controls were done for the Westerns in [Figure 1](#fig1){ref-type="fig"}, or provide appropriate loading controls.

-- The authors should provide more details about the physiology with representative examples, showing recording and stimulation sites, and a few more suggested analyses.

In general, more details are needed in the Materials and methods, such as the volume of injected virus, representative example of microinjections the rationale for using a 20% cut-off for excitation or inhibition should be provided, etc.

Reviewer \#1:

This study investigates the role of prenatal glucocorticoids (GCs) on the LDT-VTA circuitry and its impact on reward-related behavior. In their study, the authors use a rat model of in utero GC (iuGC) exposure at gestation days 18 and 19, which shows long-lasting changes in the cholinergic system (i.e., increased number of ChAT^+^ cell density and altered transcript and protein levels of the markers ChAT and AChE) in the LDT. Notably, the study stems from previous findings from the same group published in 2013 (Borges et al., 2013) where, similarly, they reported differences in ChAT^+^ cell density in LDT induced by the same glucocorticoid treatment. Here, AChE expression analysis was added, as well as analyses performed at different time points and expression at the mRNA and protein levels. The characterization of the LDT-VTA circuit with in vivo electrophysiology revealed a decreased basal neuronal activity of the LDT, but not VTA, in iuGC animals. LDT stimulation showed a decreased magnitude of excitation and an increase in VTA inhibition, likely resulting from a shift of the cell-types that respond to the stimulus. Accompanying these described LDT-VTA dysfunctions, the authors demonstrate that iuGC rats exhibit motivational deficits in the willingness to work for food, which were rescued by optogenetic activation of the LDT-VTA pathway. Furthermore, iuGC animals are more susceptible to the reinforcing properties of LDT-VTA stimulation (rats exposed to glucocorticoids in utero were more sensitive to optogenetic stimulation of LDT-VTA projections to develop conditioned place preference). The authors conclude that iuGC exposure affects the LDT-VTA circuit and results in motivational deficits.

The work is interesting and the findings relevant. Nevertheless, there are issues and concerns that require clarification:

1\) It is not clear why the work does not follow up on the identified changes on ChAT and AChE directly, as no specific manipulation assessed the role of cholinergic projections from the LDT to the VTA.

2\) As raised by the authors themselves, they have carried out their rescue experiments by activating all LDT inputs and not distinguishing between cholinergic, glutamatergic and GABAergic neurons in the LDT. The authors mention in the introduction that there are contributions of glutamatergic projections from the LDT to the VTA; it would make sense to study glutamatergic markers as well to assess whether the effect of prenatal glucocorticoid exposure is specific to the cholinergic input from LDT to VTA or not and bridge the different parts of the work.

3\) A two-way ANOVA with age and glucocorticoid treatment as factors, followed by post-hoc tests seem more appropriate than individual t-test or Mann-Whitney tests for every age.

4\) Key questions not answered by the study: Are there differences in GR expression levels in the LDT or corticosterone levels in these animals at different developmental stages that accompany the observed effects on the expression of cholinergic enzymes? Is the observed effect the result of a new equilibrium set after the in utero treatment, or is it perpetuated through differences in GR expression or corticosterone levels?

5\) In the optical stimulation experiments, control rats were treated only with an AAV-EF1a-DIO-hChR2-YFP virus. How did the authors check for proper viral injection? In addition, there seems to be no control for any effects Cre expression alone might have. The best control would be treatment with the same Cre-expressing virus in the VTA expressing only GFP in the LDT.

6\) In [Figure 1, a](#fig1){ref-type="fig"} representative immunoblot of ChAT and AChE in the LDT is represented followed by quantification of the bands. Why only one GAPDH loading control? Did the authors run an immunoblot for both proteins and then strip their membrane, which would explain one GAPDH control, or did they use two independent membranes for ChAT and AChE? In the latter case, they should please provide also a GAPDH loading control for their second membrane, which they used for the quantification plot in [Figure 1F](#fig1){ref-type="fig"}. Please provide this information in material and methods.

7\) The article would benefit by providing (molecular) background regarding the rationale to analyze cholinergic markers in iuGC animals.

8\) The article would benefit from a more detailed description about the statistical tests used for the experiments. Specifically, did they use multiple correction for [Figure 1, C, D and F](#fig1){ref-type="fig"}? And for [Figure 2F](#fig2){ref-type="fig"}? The authors report the p-values in an exemplary manner as APA-Style. Could the authors please also provide these data for [Figure 3C](#fig3){ref-type="fig"}? In subsection "iuGC treatment impairs the LDT-VTA circuitry": Please check whether the p-value of 0.008 for the magnitude is correct. It seems improbable given that t(30) = 3.723.

Reviewer \#2:

This manuscript by Coimbra and colleagues follows up on several papers by the same group pointing out the effects of iuGC exposure, this time describing motivational deficits in adult rats with the LDT-\>VTA interaction involved in such deficits. They presented evidence about an increased number of Chat neurons (and an increase in Chat RNA or protein levels) in the LDT from adult rats. They performed recordings in the LDT and VTA to measure the basal level of activity, electrically stimulated in the LDT to record its effect in the VTA, optogenetic stimulated the LDT-\>VTA terminals in the VTA evaluating the excitation/inhibition responses of VTA. And also show evidence of an altered response in the break point task in the iuGC model, which was reverted by LDT stimulation. Importantly, this last experiment showed temporal specificity of the stimulation.

Based on the evaluation of the evidence presented, this reviewer considers that this manuscript is suitable for publication attending the following points.

[Figure 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}

Specify what were the animals doing when the baseline described was acquired.

Present a distribution of the waveform duration vs. the firing rate.

Discuss the mechanisms behind the difference in latencies when comparing the LDT-VTA responses in the control vs. the iuGC groups.

About the statement citing [Figure 2](#fig2){ref-type="fig"}: Altogether, these data demonstrated an imbalance in the excitatory and inhibitory inputs from the LDT. I suggest: Altogether, these data demonstrated an imbalance in the excitatory and inhibitory inputs to the VTA when electrically stimulating in the LDT.

Why did the optogenetic stimulation was not performed in the LDT?

Please show images of the LDT cells expressing ChR2.

Why, if [Figure 3E](#fig3){ref-type="fig"} shows overall more decreased responses, is this not reflected in [Figure 3D](#fig3){ref-type="fig"}? May it be by a different probability to record from pDA or pGABAergic units in each group?

[Figure 4](#fig4){ref-type="fig"}.

When presenting that activation of LDT terminals in the VTA during cue exposure period normalized the breakpoint of iuGC animals but had no effect in CTR animals, I suggest to place it next to the other protocol (both in text and figures). In this sense, it is clearer to the reader that LDT(ChR2)-\>VTA stimulation revert the effect on the break point rather than normalizing it.

[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}.

For the analysis of locomotion in the LDT-\>VTA please plot the distance aligned to each time of the stimulation: that may reveal a different conclusion (see DOI: 10.1371/journal.pone.0033612).

Reviewer \#3 (General assessment and major comments (Required)):

This is an exceptional study combining several state-of-the-art neurobiology approaches and providing a convincing demonstration of the effect of pre-natal stress-like conditions in the neural circuits of motivation. The manuscript is very-well presented, the data are clear, and most controls (positive and negative) have been provided. This was clearly a well-designed series of experiments which ended-up with extremely convincing conclusions. All claims made by the authors was well-supported by the presented data.

Overall, I have no concerns with this study and i believe that it should be published as is.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for submitting your article \"Impairments in laterodorsal tegmentum to VTA projections underlie glucocorticoid-triggered reward deficits\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Eric Dumont (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. Although the reviewers feel that the manuscript has been improved, they think some points need additional clarification before the study can be acceptable for publication.

Reviewer \#2:

Based on the evidence presented this reviewer considers that this manuscript is suitable for publication only suggesting further attention to the following points:

Original point: Present a distribution of the waveform duration vs. the firing rate.

Response from the authors: In accordance with the reviewer\'s suggestion, we have now included additional graphs in [Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"} presenting the waveform duration vs. the firing rate of recorded cells.

Original point: Discuss the mechanisms behind the difference in latencies when comparing the LDT-VTA responses in the control vs. the iuGC groups.

Response from the authors: Thank you for raising this point \[...\] Does the reviewer have any idea/suggestion?

Further request to address this point: Previously when requesting to discuss the mechanisms behind the difference in latencies when comparing the LDT-VTA responses in the control versus the iuGC groups I was looking for an explanation based on mechanism as now is provided (perhaps also discussing axonal conductivity, note that when stimulating the LDT axons in the VTA no changes in latency are observed; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), but also a discussion with the pre-existing measurements of this latency (if there is any by other groups), since a 1ms latency seems to fast, calling attention as if the stimulating electrode may not have been positioned exactly in the LDT.

Original point: Why, if [Figure 3E](#fig3){ref-type="fig"} shows overall more decreased responses, is this not reflected in [Figure 3D](#fig3){ref-type="fig"}? May it be by a different probability to record from pDA or pGABAergic units in each group?

Response from the authors: We agree with the reviewer. In fact, the probability of recording pDAergic and pGABAergic units is different in the VTA region. We have a higher recruitment of pDAergic cells upon optical stimulation, which is in accordance with anatomical studies showing the preferential inputs of the LDT to mesoaccumbal DAergic cells in the VTA (Omelchenko and Sesack, 2005).

Original point: [Figure 4](#fig4){ref-type="fig"}. When presenting that activation of LDT terminals in the VTA during cue exposure period normalized the breakpoint of iuGC animals but had no effect in CTR animals, I suggest to place it next to the other protocol (both in text and figures). In this sense, it is clearer to the reader that LDT(ChR2)-\>VTA stimulation revert the effect on the break point rather than normalizing it.

Response from the authors: We are not certain that we understood this comment. [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}. We have made some changes in the behavioral graphs of the manuscript, please check.

Further request to address this point: The point was that the optogenetic stimulation of the LDT terminals is not specific to normalize the breakpoint of iuGC animals, since activating this terminal using a stronger protocol also increase the break point in either control or iuGC animals.

Original point: For the analysis of locomotion in the LDT-\>VTA please plot the distance aligned to each time of the stimulation, that may reveal a different conclusion (see DOI: 10.1371/journal.pone.0033612).

Response from the authors: We analyzed the paper mentioned, but we did not fully understand what the reviewer asks for. We have now included an additional graph with total distance travelled. Please check if this is what you asked for.

Further request to address this point: When stating: Moreover, no effects in locomotion \[...\] were observed using the same stimulation parameters in either group ([Figure 4---figure supplement 1E-F](#fig4s1){ref-type="fig"}). This conclusion arises from the analysis performed (one point measured every tens of milliseconds) however an immediate effect on locomotion cannot be discharged (in the range of milliseconds). I previously pointed to the DOI: 10.1371/journal.pone.0033612 because it was one of the few papers at that time recognizing that there are motor modulations when manipulating VTA Dopaminergic cells activity. Please perform a smaller bin analysis of the data evaluating the manipulations on locomotion.

Reviewer \#3:

This revised version of the manuscript has been substantially improved and addressed several if not all of my concerns. The manuscript now includes important missing control data (e.g. CRE and viral expression). When appropriate the authors substantiated their rationale and claims.

10.7554/eLife.25843.014

Author response

*The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. The reviewers find the work interesting and relevant but raise a few important points that should be addressed. Attached are the point-by-point comments of the reviewers, but below are the more relevant issues to be addressed.*

*-- In the optical stimulation experiments, there should be controls for Cre expression and viral expression. The use of a Cre dependent virus expressing GFP would be advisable.*

We have performed an additional experiment, including a new control group which consists in the injection of AAV5--EF1a--WGA--Cre--mCherry in the VTA and AAV5--EF1a--DIO--YFP in the LDT -- please check answers to reviewers below.

*-- The article would benefit from a more detailed description and a more specific use of statistics. For example, a two-way ANOVA with age and glucocorticoid treatment as factors, followed by post-hoc tests seem more appropriate than individual t-test or Mann-Whitney tests for every age. Also, the rationale for the use or not of specific statistical tests, multiple comparison corrections, etc. should be provided.*

We have taken this comment into consideration.

*-- Are there differences in GR expression levels in the LDT or corticosterone levels in these animals at different developmental stages that accompany the observed effects on the expression of cholinergic enzymes? Is the observed effect the result of a new equilibrium set after the in-utero treatment, or is it perpetuated through differences in GR expression or corticosterone levels?*

Most likely due to a new equilibrium set after the in-utero treatment, as we discuss below in response to reviewer 1.

*-- The authors should specify how the loading controls were done for the Westerns in [Figure 1](#fig1){ref-type="fig"}, or provide appropriate loading controls.*

Done -- please check answers to reviewers below.

*-- The authors should provide more details about the physiology with representative examples, showing recording and stimulation sites, and a few more suggested analyses.*

We believe we have addressed all of the reviewer comments.

*In general, more details are needed in the Materials and methods, such as the volume of injected virus, representative example of microinjections the rationale for using a 20% cut-off for excitation or inhibition should be provided, etc.*

We have added the volume of injected virus (Discussion section); and the reference paper supporting the 20% cut-off decision for electrophysiological recordings (Discussion section). Figure with the optic fiber placement for each animal used in behavioral experiments is now provided ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}).

*Reviewer \#1:*

*\[...\] 1) It is not clear why the work does not follow up on the identified changes on ChAT and AChE directly, as no specific manipulation assessed the role of cholinergic projections from the LDT to the VTA.*

Thank you for raising this point, we have now explained better in the manuscript our rationale for activating all inputs and not only cholinergic. We decided to activate all inputs because we observed an effect of iuGC exposure in both excitatory and inhibitory VTA responses elicited by LDT electrical activation, suggesting that different neurotransmitters systems could be involved.

We have now added this information in subsection "Optogenetic activation of LDT terminals in the VTA elicits distinct responses in control and iuGC animals **"**of the revised manuscript.

*2) As raised by the authors themselves, they have carried out their rescue experiments by activating all LDT inputs and not distinguishing between cholinergic, glutamatergic and GABAergic neurons in the LDT. The authors mention in the introduction that there are contributions of glutamatergic projections from the LDT to the VTA; it would make sense to study glutamatergic markers as well to assess whether the effect of prenatal glucocorticoid exposure is specific to the cholinergic input from LDT to VTA or not and bridge the different parts of the work.*

We agree with the reviewer that it is interesting to study the impact of iuGC in other neuronal populations of the LDT. Thus, we have now included gene and protein expression data of glutamatergic and GABAergic markers in the LDT in the revised manuscript (subsection "Sustained cholinergic dysfunction in iuGC animals "; [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). We found no major effect in the expression levels of EAAC1, GAD1, GAD2, GAD65 and GAD67.

*3) A two-way ANOVA with age and glucocorticoid treatment as factors, followed by post-hoc tests seem more appropriate than individual t-test or Mann-Whitney tests for every age.*

Considering this comment, we believe that the way we presented these results was not clear enough, thus we decided to separate data according to ages. We presented individual t-test or Mann-Whitney tests for every age, since gene or protein expression (RT-PCR plates or Western Blot membranes) were performed on distinct animals (not repeated measures). Please check new graphs.

*4) Key questions not answered by the study: Are there differences in GR expression levels in the LDT or corticosterone levels in these animals at different developmental stages that accompany the observed effects on the expression of cholinergic enzymes? Is the observed effect the result of a new equilibrium set after the in utero treatment, or is it perpetuated through differences in GR expression or corticosterone levels?*

We agree that this is an interesting point. Previous data from our group has shown no major differences in corticosterone levels in these animals (Oliveira et al., 2006); only when we challenged these animals we observe differences in corticosterone secretion -- such as for example in dexamethasone suppression test (Oliveira et al., 2006).

Regarding GR expression, we have performed RT-PCR and western blotting against GR, which presented no significant differences between controls and iuGC animals (Results section; [Figure 1---figure supplement 3J](#fig1s3){ref-type="fig"}--L, T--V).

As the reviewer pinpoints, we believe that early life exposure to GCs reprograms the circuit, setting a new equilibrium in the inputs from the LDT to the VTA. We have now included a sentence about this in the Discussion section.

*5) In the optical stimulation experiments, control rats were treated only with an AAV-EF1a-DIO-hChR2-YFP virus. How did the authors check for proper viral injection? In addition, there seems to be no control for any effects Cre expression alone might have. The best control would be treatment with the same Cre-expressing virus in the VTA expressing only GFP in the LDT.*

The CTR group that we used (only injected with AAV5--EF1a--DIO-hChR2--YFP in the LDT) was included in order to confirm the absence of expression of the channelrhodopsin in our approach in wild-type animals, ensuring the need for transsynaptic migration of Cre protein from the VTA in order for ChR2 to be expressed.

Yet, the reviewer raised a pertinent point, therefore, we performed additional experiments to include an additional control group (designated CTR-eYFP) injected with AAV5--EF1a--WGA--Cre--mCherry in the VTA and AAV5--EF1a--DIO--YFP in the LDT. Please check the new version of the manuscript; behavioral data of [Figure 4](#fig4){ref-type="fig"}.

*6) In [Figure 1, a](#fig1){ref-type="fig"} representative immunoblot of ChAT and AChE in the LDT is represented followed by quantification of the bands. Why only one GAPDH loading control? Did the authors run an immunoblot for both proteins and then strip their membrane, which would explain one GAPDH control, or did they use two independent membranes for ChAT and AChE? In the latter case, they should please provide also a GAPDH loading control for their second membrane, which they used for the quantification plot in [Figure 1F](#fig1){ref-type="fig"}. Please provide this information in material and methods.*

This was our mistake, thank you for pointing this out. We used two different membranes, thus we used two loading controls for quantification. After ChAT and AChE blots, we then stripped each membrane to probe against the loading protein antibody.

Figure is now corrected. We have also included, in the Materials and methods section, the membrane stripping protocol performed in the immunoblots.

*7) The article would benefit by providing (molecular) background regarding the rationale to analyze cholinergic markers in iuGC animals.*

Considering the reviewer comment, we believe that the description of the rationale behind the analysis of cholinergic changes in iuGC animals was, perhaps, not clear enough. Previous results by our group have shown an increase of LDT cholinergic cells recruited after an adverse stimulus (Borges et al., 2013). This led us to evaluate when these cholinergic changes occurred and the functional relevance of such alterations.

We have now included the following text (subsection "Sustained cholinergic dysfunction in iuGC animals"): "Previous data from our team suggested that LDT cholinergic cells were differentially recruited between in response to an adverse stimulus in a model of in utero GC (iuGC) exposure at gestation days 18 and 19. Considering this, we first evaluated the impact of GCs on the cholinergic circuitry of iuGC animals.".

*8) The article would benefit from a more detailed description about the statistical tests used for the experiments. Specifically, did they use multiple correction for [Figure 1, C, D and F](#fig1){ref-type="fig"}? and for [Figure 2F](#fig2){ref-type="fig"}? The authors report the p-values in an exemplary manner as APA-Style. Could the authors please also provide these data for [Figure 3C](#fig3){ref-type="fig"}? In subsection" iuGC treatment impairs the LDT-VTA circuitry": Please check whether the p-value of 0.008 for the magnitude is correct. It seems improbable given that t(30) = 3.723.*

Thank you for this comment. We have rephrased the statistical methods used for the experiments. As stated above, we do not believe that we should compare both groups throughout development, since experiments were performed separately, so we have separated graphs according to age.

We do not understand the question regarding [Figure 2F](#fig2){ref-type="fig"}, since this refers to an example of a waveform for a putative dopaminergic or GABAergic neuron in the VTA.

In addition, we have now included the statistical data for [Figure 3C](#fig3){ref-type="fig"}.

We corrected the p-value in subsection "iuGC treatment impairs the LDT-VTA circuitry": t(30)=3.723, p=0.0008. Thank you for finding this mistake.

*Reviewer \#2:*

*\[...\] [Figure 2](#fig2){ref-type="fig"} and 3. Specify what were the animals doing when the baseline described was acquired.*

Thank you for pointing this out. Electrophysiological recordings were acquired in anesthetized animals; we have included this description in the Results section of the manuscript (it was previously in the Materials and method section only).

*Present a distribution of the waveform duration vs. the firing rate.*

In accordance with the reviewer's suggestion, we have now included additional graphs in [Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"} presenting the waveform duration vs. the firing rate of recorded cells.

*Discuss the mechanisms behind the difference in latencies when comparing the LDT-VTA responses en the control vs. the iuGC groups.*

Thank you for raising this point. So far, we have no data supporting any explanation for this observation. Our data suggests that both LDT and VTA neurons are changed by iuGC exposure (we see a reduction in TH staining in VTA for example -- Leao et al., 2007). Both presynaptic (less acetylcholine being released for example?) and postsynaptic mechanisms (less receptors in VTA dendrites?) can contribute for the increased latency of response. However, because we do not have enough data to support either hypothesis, we decided not to discuss it in detail. However we added the following text (Discussion section): "Another remarkable finding was that the latency of excitatory responses in the VTA upon LDT electrical stimulation was substantially increased in iuGC animals, though so far we do not have any valid explanation for this. A combination of pre- and post-synaptic iuGC-induced changes may contribute for the observed increased latency in excitatory responses, thus more studies are needed in order to dissect this phenomenon."

Does the reviewer have any ideas/suggestions?

*About the statement citing [Figure 2](#fig2){ref-type="fig"}: Altogether, these data demonstrated an imbalance in the excitatory and inhibitory inputs from the LDT. I suggest: Altogether, these data demonstrated an imbalance in the excitatory and inhibitory inputs to the VTA when electrically stimulating in the LDT.*

In accordance with the reviewer's suggestion, we have corrected the above-mentioned sentence.

*Why did the optogenetic stimulation was not performed in the LDT?*

Neurons of the LDT are known to send axon collaterals to other brain regions that in turn could project to VTA, modulating VTA activity. To avoid this confounding/indirect effect, we have decided to activate only the terminals in the VTA. This was now explained in more detail in the manuscript in the Results subsection "iuGC treatment impairs the LDT-VTA circuitry"

*Please show images of the LDT cells expressing ChR2.*

We have included an image showing LDT cell soma expressing ChR2 (now [Figure 2C](#fig2){ref-type="fig"}).

*Why, if [Figure 3E](#fig3){ref-type="fig"} shows overall more decreased responses, is this not reflected in [Figure 3D](#fig3){ref-type="fig"}? May it be by a different probability to record from pDA or pGABAergic units in each group?*

We agree with the reviewer. In fact, the probability of recording pDAergic and pGABAergic units is different in the VTA region. We have a higher recruitment of pDAergic cells upon optical stimulation, which is in accordance with anatomical studies showing the preferential inputs of the LDT to mesoaccumbal DAergic cells in the VTA (Omelchenko and Sesack, 2005).

[Figure 4](#fig4){ref-type="fig"}.

*When presenting that activation of LDT terminals in the VTA during cue exposure period normalized the breakpoint of iuGC animals but had no effect in CTR animals, I suggest to place it next to the other protocol (both in text and figures). In this sense, it is clearer to the reader that LDT(ChR2)-\>VTA stimulation revert the effect on the break point rather than normalizing it.*

We are not certain that we understood this comment. We have made some changes in the behavioral graphs of the manuscript, please check.

[Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}.

*For the analysis of locomotion in the LDT-\>VTA please plot the distance aligned to each time of the stimulation, that may reveal a different conclusion (see DOI: 10.1371/journal.pone.0033612).*

We analyzed the paper mentioned, but we did not fully understand what the reviewer asks for. We have now included an additional graph with total distance travelled. Please check if this is what you asked for.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

*The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission. Although the reviewers feel that the manuscript has been improved, they think some points need additional clarification before the study can be acceptable for publication.*

*Reviewer \#2:*

*\[...\] Previously I requested a distribution of waveform duration versus the firing rate to be able to evaluate the criteria used for classification as pDAergic versus pGABAergic unit. Now when reviewing [Figure 2](#fig2){ref-type="fig"} it is clear what criteria was used, however, it is not clear why there are few blue points (pDAergic) overlapping with the category \"other\" in [Figure 3](#fig3){ref-type="fig"}.*

The reviewer is completely right; there was a mistake in the categorization of 4 cells that should have been considered as "other" instead of DAergic. These cells presented a firing rate below 10Hz (firing rate of cell 1: 5.32; cell 2: 5.46; cell 3: 5.53; cell 4: 5.57) and waveform duration below 1.5 ms (duration of cell 1: 0.8; cell 2: 1.2; cell 3: 1.32; cell 4: 1.37). We have now reanalyzed all the electrophysiological data of [Figure 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"} and corrected the figures and associated statistics. It is important to refer that reanalyzed results are very similar to previous ones and do not change the message of the manuscript.

*\[...\] Previously when requesting to discuss the mechanisms behind the difference in latencies when comparing the LDT-VTA responses in the control versus the iuGC groups I was looking for an explanation based on mechanism as now is provided (perhaps also discussing axonal conductivity, note that when stimulating the LDT axons in the VTA no changes in latency are observed; Figure ---figure supplement 1), but also a discussion with the pre-existing measurements of this latency (if there is any by other groups), since a 1ms latency seems to fast, calling attention as if the stimulating electrode may not have been positioned exactly in the LDT.*

This is an interesting point. We have made an extensive revision of the bibliography and though many studies have performed electrical/optogenetic stimulation of LDT-VTA circuit, there is no information regarding the latency of responses.

Seminal studies (Forster et al., 2000; Yeomans, 2001, amongst others) performing electrical stimulation of the LDT and recordings in the VTA show electrophysiological responses in a widespread temporal window (minute scale), not presenting any data regarding latencies.

Recent studies (Lammel et al., 2012; Dautan et al., 2016; Steidl et al., 2017) using optogenetic manipulation of LDT-VTA circuit present behavioral and general electrophysiological responses to optical stimulation but no detailed information about types of cells that respond, latencies of responses etc. Therefore, the lack of information does not allow us to compare our responses to other studies in the field.

We would like to refer that, though we also think that the latency is very short, we do not believe that it is not due to incorrect positioning since we have confirmed the recording/stimulation electrode placement by histology for all animals (depicted in [Figure 2A](#fig2){ref-type="fig"}).

Nevertheless, the reviewer raised an important point, which is the similar response latency upon optical stimulation of LDT-VTA terminals. Accordingly, we have briefly discussed this topic in the current version of the manuscript (Discussion section).

*\[...\] When asking to explain the differences in the previous [Figures 3E and 3F](#fig3){ref-type="fig"} (now 3E and 3G) and suggesting a possible explanation I am looking for a clearer explanation since it is not clear how to conceal the results of these two plots.*

We thank the reviewer for being persistent in this point. After reanalyzing the data, we found that the graph in [Figure 3G](#fig3){ref-type="fig"} had a mistake in the columns percentage. We have now re-confirmed all the electrophysiological data, corrected cell categorization, and calculated new percentages of response. A correct version of the graph is now provided, please see figure and associated legends and text (subsection "Activation of LDT terminals in the VTA rescues motivational deficits of iuGC animals").

*\[...\] The point was that the optogenetic stimulation of the LDT terminals is not specific to normalize the breakpoint of iuGC animals, since activating this terminal using a stronger protocol also increase the break point in either control or iuGC animals.*

We have changed the word "normalize" to "revert" as the reviewer suggests -- please see subsection "Surgery and cannula implantation". We did not place the graphs with stronger optogenetic stimulation in main [Figure 4](#fig4){ref-type="fig"} because this figure is already very busy with behavioral data.

*\[...\] When stating: Moreover, no effects in locomotion were observed using the same stimulation parameters in either group ([Figure 4---figure supplement 1E--F](#fig4s1){ref-type="fig"}). This conclusion arises from the analysis performed (one point measured every tens of milliseconds) however an immediate effect on locomotion cannot be discharged (in the range of milliseconds). I previously pointed to the DOI: 10.1371/journal.pone.0033612 because it was one of the few papers at that time recognizing that there are motor modulations when manipulating VTA Dopaminergic cells activity. Please perform a smaller bin analysis of the data evaluating the manipulations on locomotion.*

Thank you for explaining this point in more detail. Unfortunately, we are not able to perform a smaller bin analysis of the locomotion data. The data output depends on the parameters chosen *a priori* during the behavior task, i.e. if data is selected to be collected at each second; we cannot analyze a smaller period than that.

Nevertheless, with the stimulation used in this study, we believe that we should not observe major effects in locomotion based on current bibliography: as elegantly showed in a study by Xiao and colleagues (Xiao et al., 2016), only when targeting the pedunculopontine nucleus, but not the LDT cholinergic projections specifically, they were able to see an effect on locomotor behavior. Additionally, in a previous study (Lammel et al., 2012), authors reported no effect of optical stimulation of all inputs from the LDT to the VTA in locomotion.
